FastAb proposes a rapid and efficient system, in auto-test format, to detect the immune status as regards multiple infections simultaneously. The system allows the automated gathering of information on the prevalence and seroconversion of the global population to several diseases; it thus provides epidemic intelligence that will help to design and implement strategies to fight epidemics and to plan pharmaceutical developments.
The FastAb system is possible thanks to the advantages provided by the MELISA technology, developed and patented by CIC biomaGUNE. They include low production costs, design flexibility, detection sensitivity and the reagent stability.
The general population is the target of this auto-test detection system. The epidemic data gathered are for the national health systems and the pharmaceutical industry.
Para participar en esta iniciativa, tanto aportando activos tecnológicos como si eres un talento promotor con capacidad para convertirlos en proyectos empresariales, rellena este formulario y te contactaremos
Entrepreneurship
Entrepreneurship
For SMEs, for diversifying markets, internships abroad, international tenders, non-reimbursable subsidies to consolidate exports, subsidies for deployments or specific training in internationalisation.
You’re interested, right?
